Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810 is registered in ClinicalTrials.gov with Angiochem Inc as lead sponsor.

NCT NCT01967810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients With Recurrent High-Grade Glioma
Lead sponsor
Angiochem Inc
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2017
Enrollment
73 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, glioblastoma, glioma